Welcome!

News Feed Item

Innovative Luneray catheters and organ-preserving approach result in radically less invasive bladder cancer treatment

Urologist and radiation oncologist collaborate in laparoscopic implantation of new brachytherapy catheters for bladder cancer

ARNHEM, Netherlands, April 7, 2014 /PRNewswire/ -- Physicians at Arnhem Radiotherapy Institute (ARTI) and Rijnstate Hospital have dramatically transformed brachytherapy to treat bladder cancer. By employing new sophisticated Luneray™ brachytherapy catheters by Nucletron, an Elekta company, and robot-assisted laparoscopy, clinicians can treat bladder cancer patients far less invasively than previously possible, enabling bladder preservation in an increased number of patients.

On January 20, ARTI radiation oncologist Dr. Elzbieta van der Steen-Banasik and Rijnstate urologist Dr. Geert Smits used the technique they developed to treat an 80-year-old male patient with bladder cancer. He was the first in which the physicians debuted the recently introduced Luneray brachytherapy catheters. The ARTI-Rijnstate clinicians have been working in close collaboration with Nucletron perfecting the needle-catheter solution.

"The patient had a small T3 tumor that we treated initially with a four-week course of external beam radiation therapy (EBRT)," Dr. Smits says. "We then removed a bladder diverticule – where the tumor was located – with a partial cystectomy.  During the same procedure we implanted two Luneray catheters using our robot-assisted laparoscopic approach and delivered the first of 10 brachytherapy fractions of 2.5 Gy each. The remaining nine fractions were delivered over the next three days. After the tenth fraction, the catheters were removed and the patient went home. There were no complications and he is doing well."

ARTI-Rijnstate's laparoscopic method with Luneray is a vast improvement over the traditional open surgical procedure for implanting brachytherapy catheters. After an initial EBRT course, the traditional method involved a large incision to expose the bladder, then opening the bladder for implantation of catheters. This complex procedure often incurs lengthy hospitalization and the possibility of wound and bladder infections.

"The laparoscopic technique involves just four 8-10 mm incisions in the abdominal wall for the insertion of instruments and, in most cases, minimal manipulation of the bladder wall, resulting in significant reduction in tissue trauma," Dr. van der Steen-Banasik explains. "Also hospitalization is dramatically shorter – an average of just six days, versus 17 days on average for the open procedure." 

Innovative Luneray needle-catheter
The Luneray catheters are a critical component in the success of ARTI-Rijnstate's minimally invasive bladder brachytherapy program. Both Dr. Smits and Dr. van der Steen-Banasik worked together with Nucletron to create an entirely new class of pre-assembled brachytherapy needle/catheter applicators for laparoscopic use. The needles have a slight curve to enable optimal access to the targeted part of the bladder. The catheters are made of the same innovative material as the also recently introduced LumenCare™ Azure applicator for lung brachytherapy. This unique material makes the applicators strong, yet flexible and highly kink-resistant.

"The availability of Luneray catheters really creates new possibilities to treat selected bladder cancers in a minimally invasive way using brachytherapy," Dr. van der Steen-Banasik observes. "We hope that more patients will benefit from this bladder-sparing treatment in the future."

*Luneray is pending US FDA 510(k) clearance and not available for sale or distribution in all markets.

For further information, please contact:
Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: [email protected]
Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, e-mail: [email protected]
Time zone: EST: Eastern Standard Time

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.

SOURCE Elekta

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Most DevOps journeys involve several phases of maturity. Research shows that the inflection point where organizations begin to see maximum value is when they implement tight integration deploying their code to their infrastructure. Success at this level is the last barrier to at-will deployment. Storage, for instance, is more capable than where we read and write data. In his session at @DevOpsSummit at 20th Cloud Expo, Josh Atwell, a Developer Advocate for NetApp, will discuss the role and value...
"When you think about the data center today, there's constant evolution, The evolution of the data center and the needs of the consumer of technology change, and they change constantly," stated Matt Kalmenson, VP of Sales, Service and Cloud Providers at Veeam Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Today, we have more data to manage than ever. We also have better algorithms that help us access our data faster. Cloud is the driving force behind many of the data warehouse advancements we have enjoyed in recent years. But what are the best practices for storing data in the cloud for machine learning and data science applications?
Andi Mann, Chief Technology Advocate at Splunk, is an accomplished digital business executive with extensive global expertise as a strategist, technologist, innovator, marketer, and communicator. For over 30 years across five continents, he has built success with Fortune 500 corporations, vendors, governments, and as a leading research analyst and consultant.
A valuable conference experience generates new contacts, sales leads, potential strategic partners and potential investors; helps gather competitive intelligence and even provides inspiration for new products and services. Conference Guru works with conference organizers to pass great deals to great conferences, helping you discover new conferences and increase your return on investment.
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
DXWorldEXPO LLC announced today that ICOHOLDER named "Media Sponsor" of Miami Blockchain Event by FinTechEXPO. ICOHOLDER gives detailed information and help the community to invest in the trusty projects. Miami Blockchain Event by FinTechEXPO has opened its Call for Papers. The two-day event will present 20 top Blockchain experts. All speaking inquiries which covers the following information can be submitted by email to [email protected] Miami Blockchain Event by FinTechEXPOalso offers sp...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science" is responsible for guiding the technology strategy within Hitachi Vantara for IoT and Analytics. Bill brings a balanced business-technology approach that focuses on business outcomes to drive data, analytics and technology decisions that underpin an organization's digital transformation strategy.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term.
Headquartered in Plainsboro, NJ, Synametrics Technologies has provided IT professionals and computer systems developers since 1997. Based on the success of their initial product offerings (WinSQL and DeltaCopy), the company continues to create and hone innovative products that help its customers get more from their computer applications, databases and infrastructure. To date, over one million users around the world have chosen Synametrics solutions to help power their accelerated business or per...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Sanjeev Sharma Joins November 11-13, 2018 @DevOpsSummit at @CloudEXPO New York Faculty. Sanjeev Sharma is an internationally known DevOps and Cloud Transformation thought leader, technology executive, and author. Sanjeev's industry experience includes tenures as CTO, Technical Sales leader, and Cloud Architect leader. As an IBM Distinguished Engineer, Sanjeev is recognized at the highest levels of IBM's core of technical leaders.
@DevOpsSummit at Cloud Expo, taking place November 12-13 in New York City, NY, is co-located with 22nd international CloudEXPO | first international DXWorldEXPO and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time t...
DXWorldEXPO LLC announced today that Kevin Jackson joined the faculty of CloudEXPO's "10-Year Anniversary Event" which will take place on November 11-13, 2018 in New York City. Kevin L. Jackson is a globally recognized cloud computing expert and Founder/Author of the award winning "Cloud Musings" blog. Mr. Jackson has also been recognized as a "Top 100 Cybersecurity Influencer and Brand" by Onalytica (2015), a Huffington Post "Top 100 Cloud Computing Experts on Twitter" (2013) and a "Top 50 C...
When talking IoT we often focus on the devices, the sensors, the hardware itself. The new smart appliances, the new smart or self-driving cars (which are amalgamations of many ‘things'). When we are looking at the world of IoT, we should take a step back, look at the big picture. What value are these devices providing. IoT is not about the devices, its about the data consumed and generated. The devices are tools, mechanisms, conduits. This paper discusses the considerations when dealing with the...